Loading…
Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model
Hepatitis B virus X protein (HBx) plays important roles in the development of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) contribute to cancer development by acting as oncogenes or tumor suppressors. Previously, we reported that HBx was able to promote the migration of hepatoma HepG2 cells. H...
Saved in:
Published in: | PloS one 2011-05, Vol.6 (5), p.e19518-e19518 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c757t-6dfaf96a5e9adc770811c8ebe9888312117a362fe6f3f04c4c9e25f1cf438ea73 |
---|---|
cites | cdi_FETCH-LOGICAL-c757t-6dfaf96a5e9adc770811c8ebe9888312117a362fe6f3f04c4c9e25f1cf438ea73 |
container_end_page | e19518 |
container_issue | 5 |
container_start_page | e19518 |
container_title | PloS one |
container_volume | 6 |
creator | Kong, Guangyao Zhang, Junping Zhang, Shuai Shan, Changliang Ye, Lihong Zhang, Xiaodong |
description | Hepatitis B virus X protein (HBx) plays important roles in the development of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) contribute to cancer development by acting as oncogenes or tumor suppressors. Previously, we reported that HBx was able to promote the migration of hepatoma HepG2 cells. However, the regulation of miRNAs in the development of HBV-related HCC is poorly understood. In the present study, we reported that miR-29a was a novel regulator of migration of hepatoma cells mediated by HBx. Our data showed that the expression of miR-29a was dramatically increased in p21-HBx transgenic mice, HBx-transfected hepatoma HepG2-X (or H7402-X) cells and HepG2.2.15 cells that constitutively replicate HBV. However, our data showed that miR-29a was upregulated in 4 of the 11 clinical HCC samples. We found that the overexpression of miR-29a promoted the migration of HepG2 cells, while a specific miR-29a inhibitor could partially abolish the enhanced migration of HepG2-X cells. Moreover, we identified PTEN was one of the target genes of miR-29a in HepG2 cells. The deletion of the miR-29a-binding site was able to abolish the role of miR-29a in suppression of luciferase activity of the PTEN 3'UTR reporter. Meanwhile, the overexpression of PTEN was able to reverse the promoted migration of HepG2 cells mediated by miR-29a. Moreover, our data showed that the modulation of Akt phosphorylation, a downstream factor of PTEN, was involved in the cell migration enhanced by miR-29a, suggesting that miR-29a is responsible for the cell migration through its target gene PTEN. Thus, we conclude that miR-29a is involved in the regulation of migration of hepatoma cells mediated by HBx through PTEN in cell culture model. |
doi_str_mv | 10.1371/journal.pone.0019518 |
format | article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1294885635</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A476892103</galeid><doaj_id>oai_doaj_org_article_d4ba901f2da848e8b59adbb5c16ec8d6</doaj_id><sourcerecordid>A476892103</sourcerecordid><originalsourceid>FETCH-LOGICAL-c757t-6dfaf96a5e9adc770811c8ebe9888312117a362fe6f3f04c4c9e25f1cf438ea73</originalsourceid><addsrcrecordid>eNqNk8Fu1DAQhiMEoqXwBggiIYE47BLHieNckJaqwEpVi0qLuFmOM8565cTBdip649Fxumm1QT0gH2zZ3_-PPZ6JopcoWSJcoA9bM9iO62VvOlgmCSpzRB9Fh6jE6YKkCX68tz6Injm3TZIcU0KeRgcpyguMCDmM_lz1FppBcw913CphzcXZapGWPK5u4g303CuvXPwpvlZ2cPHPuLfGg-pi6Da8E-B2kGl5LEDrYNHYoDHdqPfcNuBV18TfLk_O4qC6ZcSg_WAhbk0N-nn0RHLt4MU0H0VXn08uj78uTs-_rI9XpwtR5IVfkFpyWRKeQ8lrURQJRUhQqKCklGKUIlRwTFIJRGKZZCITJaS5REJmmAIv8FH0eufba-PYlDzHUFpmlOYE54FY74ja8C3rrWq5vWGGK3a7YWzDuPVKaGB1VvEyQTKtOc0o0CoPt6qqXCACgtYkeH2cog1VC7WAzluuZ6bzk05tWGOuGU4oJQUNBu8mA2t-DeA8a5Ubs8c7MINjAcJpnpYj-eYf8uHHTVTDw_1VJ00IK0ZPtsoKQssUJThQyweoMGoItREKTaqwPxO8nwkC4-G3b_jgHFt_v_h_9vzHnH27x26Aa79xRg9jZbk5mO3AULnOWZD3OUYJG_vkLhts7BM29UmQvdr_n3vRXWPgv9dXDuw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1294885635</pqid></control><display><type>article</type><title>Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model</title><source>PubMed Central (Open Access)</source><source>Publicly Available Content Database</source><creator>Kong, Guangyao ; Zhang, Junping ; Zhang, Shuai ; Shan, Changliang ; Ye, Lihong ; Zhang, Xiaodong</creator><contributor>Pfeffer, Sebastien</contributor><creatorcontrib>Kong, Guangyao ; Zhang, Junping ; Zhang, Shuai ; Shan, Changliang ; Ye, Lihong ; Zhang, Xiaodong ; Pfeffer, Sebastien</creatorcontrib><description>Hepatitis B virus X protein (HBx) plays important roles in the development of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) contribute to cancer development by acting as oncogenes or tumor suppressors. Previously, we reported that HBx was able to promote the migration of hepatoma HepG2 cells. However, the regulation of miRNAs in the development of HBV-related HCC is poorly understood. In the present study, we reported that miR-29a was a novel regulator of migration of hepatoma cells mediated by HBx. Our data showed that the expression of miR-29a was dramatically increased in p21-HBx transgenic mice, HBx-transfected hepatoma HepG2-X (or H7402-X) cells and HepG2.2.15 cells that constitutively replicate HBV. However, our data showed that miR-29a was upregulated in 4 of the 11 clinical HCC samples. We found that the overexpression of miR-29a promoted the migration of HepG2 cells, while a specific miR-29a inhibitor could partially abolish the enhanced migration of HepG2-X cells. Moreover, we identified PTEN was one of the target genes of miR-29a in HepG2 cells. The deletion of the miR-29a-binding site was able to abolish the role of miR-29a in suppression of luciferase activity of the PTEN 3'UTR reporter. Meanwhile, the overexpression of PTEN was able to reverse the promoted migration of HepG2 cells mediated by miR-29a. Moreover, our data showed that the modulation of Akt phosphorylation, a downstream factor of PTEN, was involved in the cell migration enhanced by miR-29a, suggesting that miR-29a is responsible for the cell migration through its target gene PTEN. Thus, we conclude that miR-29a is involved in the regulation of migration of hepatoma cells mediated by HBx through PTEN in cell culture model.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0019518</identifier><identifier>PMID: 21573166</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>3' Untranslated regions ; 3' Untranslated Regions - genetics ; AKT protein ; Analysis ; Animals ; B cells ; Binding sites ; Biology ; Blotting, Western ; Breast cancer ; Carcinoma, Hepatocellular - genetics ; Carcinoma, Hepatocellular - metabolism ; Cell culture ; Cell Line, Tumor ; Cell migration ; Cell Movement - genetics ; Cell Movement - physiology ; Clonal deletion ; Education ; Gene expression ; Genes ; Genetic engineering ; HBX protein ; Hep G2 Cells ; Hepatitis ; Hepatitis B ; Hepatitis B virus ; Hepatocellular carcinoma ; Hepatoma ; Humans ; In Vitro Techniques ; Kinases ; Laboratories ; Leukemia ; Life sciences ; Liver cancer ; Liver Neoplasms - genetics ; Liver Neoplasms - metabolism ; Luciferase ; Lymphocytes B ; Medical research ; Medicine ; Mice ; Mice, Transgenic ; MicroRNA ; MicroRNAs ; MicroRNAs - genetics ; MicroRNAs - metabolism ; miRNA ; Molecular biology ; Phosphatase ; Phosphorylation ; Proteins ; Proto-Oncogene Proteins c-akt - genetics ; Proto-Oncogene Proteins c-akt - metabolism ; PTEN Phosphohydrolase - genetics ; PTEN Phosphohydrolase - metabolism ; PTEN protein ; Reverse Transcriptase Polymerase Chain Reaction ; Ribonucleic acid ; RNA ; RNA Interference ; Rodents ; Suppressors ; Trans-Activators - genetics ; Trans-Activators - metabolism ; Transcription factors ; Transgenic animals ; Transgenic mice ; Tumorigenesis ; Tumors ; Viruses ; X cells</subject><ispartof>PloS one, 2011-05, Vol.6 (5), p.e19518-e19518</ispartof><rights>COPYRIGHT 2011 Public Library of Science</rights><rights>2011 Kong et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Kong et al. 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c757t-6dfaf96a5e9adc770811c8ebe9888312117a362fe6f3f04c4c9e25f1cf438ea73</citedby><cites>FETCH-LOGICAL-c757t-6dfaf96a5e9adc770811c8ebe9888312117a362fe6f3f04c4c9e25f1cf438ea73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1294885635/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1294885635?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21573166$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Pfeffer, Sebastien</contributor><creatorcontrib>Kong, Guangyao</creatorcontrib><creatorcontrib>Zhang, Junping</creatorcontrib><creatorcontrib>Zhang, Shuai</creatorcontrib><creatorcontrib>Shan, Changliang</creatorcontrib><creatorcontrib>Ye, Lihong</creatorcontrib><creatorcontrib>Zhang, Xiaodong</creatorcontrib><title>Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Hepatitis B virus X protein (HBx) plays important roles in the development of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) contribute to cancer development by acting as oncogenes or tumor suppressors. Previously, we reported that HBx was able to promote the migration of hepatoma HepG2 cells. However, the regulation of miRNAs in the development of HBV-related HCC is poorly understood. In the present study, we reported that miR-29a was a novel regulator of migration of hepatoma cells mediated by HBx. Our data showed that the expression of miR-29a was dramatically increased in p21-HBx transgenic mice, HBx-transfected hepatoma HepG2-X (or H7402-X) cells and HepG2.2.15 cells that constitutively replicate HBV. However, our data showed that miR-29a was upregulated in 4 of the 11 clinical HCC samples. We found that the overexpression of miR-29a promoted the migration of HepG2 cells, while a specific miR-29a inhibitor could partially abolish the enhanced migration of HepG2-X cells. Moreover, we identified PTEN was one of the target genes of miR-29a in HepG2 cells. The deletion of the miR-29a-binding site was able to abolish the role of miR-29a in suppression of luciferase activity of the PTEN 3'UTR reporter. Meanwhile, the overexpression of PTEN was able to reverse the promoted migration of HepG2 cells mediated by miR-29a. Moreover, our data showed that the modulation of Akt phosphorylation, a downstream factor of PTEN, was involved in the cell migration enhanced by miR-29a, suggesting that miR-29a is responsible for the cell migration through its target gene PTEN. Thus, we conclude that miR-29a is involved in the regulation of migration of hepatoma cells mediated by HBx through PTEN in cell culture model.</description><subject>3' Untranslated regions</subject><subject>3' Untranslated Regions - genetics</subject><subject>AKT protein</subject><subject>Analysis</subject><subject>Animals</subject><subject>B cells</subject><subject>Binding sites</subject><subject>Biology</subject><subject>Blotting, Western</subject><subject>Breast cancer</subject><subject>Carcinoma, Hepatocellular - genetics</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Cell culture</subject><subject>Cell Line, Tumor</subject><subject>Cell migration</subject><subject>Cell Movement - genetics</subject><subject>Cell Movement - physiology</subject><subject>Clonal deletion</subject><subject>Education</subject><subject>Gene expression</subject><subject>Genes</subject><subject>Genetic engineering</subject><subject>HBX protein</subject><subject>Hep G2 Cells</subject><subject>Hepatitis</subject><subject>Hepatitis B</subject><subject>Hepatitis B virus</subject><subject>Hepatocellular carcinoma</subject><subject>Hepatoma</subject><subject>Humans</subject><subject>In Vitro Techniques</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Leukemia</subject><subject>Life sciences</subject><subject>Liver cancer</subject><subject>Liver Neoplasms - genetics</subject><subject>Liver Neoplasms - metabolism</subject><subject>Luciferase</subject><subject>Lymphocytes B</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>MicroRNA</subject><subject>MicroRNAs</subject><subject>MicroRNAs - genetics</subject><subject>MicroRNAs - metabolism</subject><subject>miRNA</subject><subject>Molecular biology</subject><subject>Phosphatase</subject><subject>Phosphorylation</subject><subject>Proteins</subject><subject>Proto-Oncogene Proteins c-akt - genetics</subject><subject>Proto-Oncogene Proteins c-akt - metabolism</subject><subject>PTEN Phosphohydrolase - genetics</subject><subject>PTEN Phosphohydrolase - metabolism</subject><subject>PTEN protein</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>Ribonucleic acid</subject><subject>RNA</subject><subject>RNA Interference</subject><subject>Rodents</subject><subject>Suppressors</subject><subject>Trans-Activators - genetics</subject><subject>Trans-Activators - metabolism</subject><subject>Transcription factors</subject><subject>Transgenic animals</subject><subject>Transgenic mice</subject><subject>Tumorigenesis</subject><subject>Tumors</subject><subject>Viruses</subject><subject>X cells</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk8Fu1DAQhiMEoqXwBggiIYE47BLHieNckJaqwEpVi0qLuFmOM8565cTBdip649Fxumm1QT0gH2zZ3_-PPZ6JopcoWSJcoA9bM9iO62VvOlgmCSpzRB9Fh6jE6YKkCX68tz6Injm3TZIcU0KeRgcpyguMCDmM_lz1FppBcw913CphzcXZapGWPK5u4g303CuvXPwpvlZ2cPHPuLfGg-pi6Da8E-B2kGl5LEDrYNHYoDHdqPfcNuBV18TfLk_O4qC6ZcSg_WAhbk0N-nn0RHLt4MU0H0VXn08uj78uTs-_rI9XpwtR5IVfkFpyWRKeQ8lrURQJRUhQqKCklGKUIlRwTFIJRGKZZCITJaS5REJmmAIv8FH0eufba-PYlDzHUFpmlOYE54FY74ja8C3rrWq5vWGGK3a7YWzDuPVKaGB1VvEyQTKtOc0o0CoPt6qqXCACgtYkeH2cog1VC7WAzluuZ6bzk05tWGOuGU4oJQUNBu8mA2t-DeA8a5Ubs8c7MINjAcJpnpYj-eYf8uHHTVTDw_1VJ00IK0ZPtsoKQssUJThQyweoMGoItREKTaqwPxO8nwkC4-G3b_jgHFt_v_h_9vzHnH27x26Aa79xRg9jZbk5mO3AULnOWZD3OUYJG_vkLhts7BM29UmQvdr_n3vRXWPgv9dXDuw</recordid><startdate>20110505</startdate><enddate>20110505</enddate><creator>Kong, Guangyao</creator><creator>Zhang, Junping</creator><creator>Zhang, Shuai</creator><creator>Shan, Changliang</creator><creator>Ye, Lihong</creator><creator>Zhang, Xiaodong</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20110505</creationdate><title>Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model</title><author>Kong, Guangyao ; Zhang, Junping ; Zhang, Shuai ; Shan, Changliang ; Ye, Lihong ; Zhang, Xiaodong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c757t-6dfaf96a5e9adc770811c8ebe9888312117a362fe6f3f04c4c9e25f1cf438ea73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>3' Untranslated regions</topic><topic>3' Untranslated Regions - genetics</topic><topic>AKT protein</topic><topic>Analysis</topic><topic>Animals</topic><topic>B cells</topic><topic>Binding sites</topic><topic>Biology</topic><topic>Blotting, Western</topic><topic>Breast cancer</topic><topic>Carcinoma, Hepatocellular - genetics</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Cell culture</topic><topic>Cell Line, Tumor</topic><topic>Cell migration</topic><topic>Cell Movement - genetics</topic><topic>Cell Movement - physiology</topic><topic>Clonal deletion</topic><topic>Education</topic><topic>Gene expression</topic><topic>Genes</topic><topic>Genetic engineering</topic><topic>HBX protein</topic><topic>Hep G2 Cells</topic><topic>Hepatitis</topic><topic>Hepatitis B</topic><topic>Hepatitis B virus</topic><topic>Hepatocellular carcinoma</topic><topic>Hepatoma</topic><topic>Humans</topic><topic>In Vitro Techniques</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Leukemia</topic><topic>Life sciences</topic><topic>Liver cancer</topic><topic>Liver Neoplasms - genetics</topic><topic>Liver Neoplasms - metabolism</topic><topic>Luciferase</topic><topic>Lymphocytes B</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>MicroRNA</topic><topic>MicroRNAs</topic><topic>MicroRNAs - genetics</topic><topic>MicroRNAs - metabolism</topic><topic>miRNA</topic><topic>Molecular biology</topic><topic>Phosphatase</topic><topic>Phosphorylation</topic><topic>Proteins</topic><topic>Proto-Oncogene Proteins c-akt - genetics</topic><topic>Proto-Oncogene Proteins c-akt - metabolism</topic><topic>PTEN Phosphohydrolase - genetics</topic><topic>PTEN Phosphohydrolase - metabolism</topic><topic>PTEN protein</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>Ribonucleic acid</topic><topic>RNA</topic><topic>RNA Interference</topic><topic>Rodents</topic><topic>Suppressors</topic><topic>Trans-Activators - genetics</topic><topic>Trans-Activators - metabolism</topic><topic>Transcription factors</topic><topic>Transgenic animals</topic><topic>Transgenic mice</topic><topic>Tumorigenesis</topic><topic>Tumors</topic><topic>Viruses</topic><topic>X cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kong, Guangyao</creatorcontrib><creatorcontrib>Zhang, Junping</creatorcontrib><creatorcontrib>Zhang, Shuai</creatorcontrib><creatorcontrib>Shan, Changliang</creatorcontrib><creatorcontrib>Ye, Lihong</creatorcontrib><creatorcontrib>Zhang, Xiaodong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database (ProQuest)</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kong, Guangyao</au><au>Zhang, Junping</au><au>Zhang, Shuai</au><au>Shan, Changliang</au><au>Ye, Lihong</au><au>Zhang, Xiaodong</au><au>Pfeffer, Sebastien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2011-05-05</date><risdate>2011</risdate><volume>6</volume><issue>5</issue><spage>e19518</spage><epage>e19518</epage><pages>e19518-e19518</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Hepatitis B virus X protein (HBx) plays important roles in the development of hepatocellular carcinoma (HCC). MicroRNAs (miRNAs) contribute to cancer development by acting as oncogenes or tumor suppressors. Previously, we reported that HBx was able to promote the migration of hepatoma HepG2 cells. However, the regulation of miRNAs in the development of HBV-related HCC is poorly understood. In the present study, we reported that miR-29a was a novel regulator of migration of hepatoma cells mediated by HBx. Our data showed that the expression of miR-29a was dramatically increased in p21-HBx transgenic mice, HBx-transfected hepatoma HepG2-X (or H7402-X) cells and HepG2.2.15 cells that constitutively replicate HBV. However, our data showed that miR-29a was upregulated in 4 of the 11 clinical HCC samples. We found that the overexpression of miR-29a promoted the migration of HepG2 cells, while a specific miR-29a inhibitor could partially abolish the enhanced migration of HepG2-X cells. Moreover, we identified PTEN was one of the target genes of miR-29a in HepG2 cells. The deletion of the miR-29a-binding site was able to abolish the role of miR-29a in suppression of luciferase activity of the PTEN 3'UTR reporter. Meanwhile, the overexpression of PTEN was able to reverse the promoted migration of HepG2 cells mediated by miR-29a. Moreover, our data showed that the modulation of Akt phosphorylation, a downstream factor of PTEN, was involved in the cell migration enhanced by miR-29a, suggesting that miR-29a is responsible for the cell migration through its target gene PTEN. Thus, we conclude that miR-29a is involved in the regulation of migration of hepatoma cells mediated by HBx through PTEN in cell culture model.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>21573166</pmid><doi>10.1371/journal.pone.0019518</doi><tpages>e19518</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2011-05, Vol.6 (5), p.e19518-e19518 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1294885635 |
source | PubMed Central (Open Access); Publicly Available Content Database |
subjects | 3' Untranslated regions 3' Untranslated Regions - genetics AKT protein Analysis Animals B cells Binding sites Biology Blotting, Western Breast cancer Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - metabolism Cell culture Cell Line, Tumor Cell migration Cell Movement - genetics Cell Movement - physiology Clonal deletion Education Gene expression Genes Genetic engineering HBX protein Hep G2 Cells Hepatitis Hepatitis B Hepatitis B virus Hepatocellular carcinoma Hepatoma Humans In Vitro Techniques Kinases Laboratories Leukemia Life sciences Liver cancer Liver Neoplasms - genetics Liver Neoplasms - metabolism Luciferase Lymphocytes B Medical research Medicine Mice Mice, Transgenic MicroRNA MicroRNAs MicroRNAs - genetics MicroRNAs - metabolism miRNA Molecular biology Phosphatase Phosphorylation Proteins Proto-Oncogene Proteins c-akt - genetics Proto-Oncogene Proteins c-akt - metabolism PTEN Phosphohydrolase - genetics PTEN Phosphohydrolase - metabolism PTEN protein Reverse Transcriptase Polymerase Chain Reaction Ribonucleic acid RNA RNA Interference Rodents Suppressors Trans-Activators - genetics Trans-Activators - metabolism Transcription factors Transgenic animals Transgenic mice Tumorigenesis Tumors Viruses X cells |
title | Upregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture model |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T20%3A54%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upregulated%20microRNA-29a%20by%20hepatitis%20B%20virus%20X%20protein%20enhances%20hepatoma%20cell%20migration%20by%20targeting%20PTEN%20in%20cell%20culture%20model&rft.jtitle=PloS%20one&rft.au=Kong,%20Guangyao&rft.date=2011-05-05&rft.volume=6&rft.issue=5&rft.spage=e19518&rft.epage=e19518&rft.pages=e19518-e19518&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0019518&rft_dat=%3Cgale_plos_%3EA476892103%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c757t-6dfaf96a5e9adc770811c8ebe9888312117a362fe6f3f04c4c9e25f1cf438ea73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1294885635&rft_id=info:pmid/21573166&rft_galeid=A476892103&rfr_iscdi=true |